News for Illumina, Inc. (ILMN.MX)

Illumina (ILMN) Faces Double Downgrade: Challenging 2026 outlook leads to downgrades from Scotiabank and Citi. Price Target Insights: Analysts offer a m

On July 11, 2025, Illumina (ILMN) received an update from Scotiabank analyst Sung Ji Nam. The analyst downgraded the rating for Illumina from "Sector Outperform

Scotiabank has revised its rating for Illumina (ILMN), moving it down to a Sector Perform from its previous Outperform standing. This adjustment comes with a ne

Scotiabank has adjusted its rating on Illumina (ILMN), moving it from an Outperform to a Sector Perform status. The bank has also established a price target for

PR NewswireSAN DIEGO, July 10, 2025 SAN DIEGO, July 10, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for t

Illumina (ILMN) to announce Q2 2025 earnings results on July 31, 2025, after market close. Earnings call scheduled for 1:30 PM Pacific Time with CEO Jac

PR NewswireSAN DIEGO, July 10, 2025 Illumina was also recognized as one of the Best Companies to Work For byU.S. News & World ReportSAN DIEGO, July 10, 202

Illumina (ILMN) secures a spot on TIME's World's Most Sustainable Companies list for the second consecutive year. The company has achieved an 80% reduct

Shares of Illumina Inc (ILMN) fell 3.17% in mid-day trading on Jul 9. The stock reached an intraday low of $95.09, before recovering slightly to $96.12, dow

Citi downgrades Illumina (ILMN) stock from Neutral to Sell due to potential growth risks. Wall Street analysts forecast an average price target of $109.

Shares of Illumina Inc (ILMN) fell 3.45% in mid-day trading on Jul 7. The stock reached an intraday low of $96.92, before recovering slightly to $97.32, dow

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors.

Illumina, Inc. (NASDAQ:ILMN) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Illumina, Inc. (NASDAQ:ILMN) announced recently that it has entered into a definitive agreement with Standard BioTools (NASDAQ:LAB) to acquire SomaLogic, a recognized leader in proteomics technology, for $350 million in cash at closing, along with up to […]

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced it has entered into a definitive agreement with Standard BioTools (NASDAQ: LAB) under which Illumina...

Ark Invest made strategic acquisitions of Shopify and Airbnb, reflecting its interest in high-growth tech and e-commerce sectors on Tuesday June 24, 2025.

We came across a bullish thesis on Illumina, Inc. (ILMN) on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on ILMN. Illumina, Inc.

Illumina (ILMN) has revealed plans to acquire SomaLogic along with certain assets from Standard BioTools for a cash sum of $350 million, subject to standard adj

Illumina (ILMN) is poised to purchase SomaLogic from Standard BioTools in a strategic transaction valued at up to $425 million. This deal includes an upfront ca

Summary On June 23, 2025, Illumina Inc (ILMN) announced a definitive agreement to acquire SomaLogic, a leader in data-driven proteomics technology, for $350 mil